eISSN: 2299-0046
ISSN: 1642-395X
Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Share:
Share:
abstract:
Review paper

Mycosis fungoides unveiled following dupilumab treatment in a patient with a history of atopic dermatitis. Usefulness of HFUS in monitoring skin features. A review with a case report

Hanna Cisoń
1
,
Wiktor Cisoń
2
,
Barbara Białynicki-Birula
2
,
Marianna Suseł
2
,
Rafał Białynicki-Birula
1
,
Jacek C. Szepietowski
1

  1. Department of Dermatology, Venereology, and Allergology, Wroclaw Medical University, Wroclaw, Poland
  2. Experimental Dermatology Circle, Student Scientific Society of Wroclaw Medical University, Wroclaw, Poland
Adv Dermatol Allergol
Online publish date: 2024/09/25
View full text Get citation
 
Dupilumab has revolutionized atopic dermatitis (AD) treatment, but concerns arise about its potential link to cutaneous T-cell lymphomas (CTCL). This review explores CTCL occurrence post-dupilumab therapy in AD and its potential therapeutic effects. A case study of a 76-year-old patient with severe AD treated with dupilumab, developing erythroderma revealing mycosis fungoides (MF), underscores the need to understand associated mechanisms and risk factors for safe dupilumab use. This case also highlights the utility of the high-frequency ultrasound in monitoring cutaneous manifestations in patients with MF.
keywords:

non-Hodgkin lymphoma, T-cell lymphoma, T-cell, MF, mycosis fungoides, dupilumab, antibodies, monoclonal, humanized, skin diseases, ultrasonography, skin imaging

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.